Monday, June 15, 2026

How ABL Bio’s Grabody-B Revolutionizes siRNA Delivery: A Game-Changer for Brain Disease Treatment?

ABL Bio's Grabody-B technology effectively delivers siRNA across the blood-brain barrier, enhancing treatment for brain and systemic diseases.

China Pulls Off Mind-Control Milestone With Brain Chip Trial

China advances brain-computer interface technology with successful trials, enabling paralyzed patients to control devices using thoughts.

Gas Prices in South Korea: Will They Drop After US-Iran Ceasefire? Insights for 2026

A U.S.-Iran ceasefire may not lead to immediate fuel price drops in South Korea, with prices expected to remain high for months.

Tag: Epyztek

Samsung Bioepis Secures U.S. Approval for Pen-Style Stelara Biosimilar, Setting a Market First

Samsung Bioepis receives FDA approval for Epyztek, the first pre-filled pen for autoimmune treatments, enhancing patient convenience.

Top News

- Our Sponsors Ad -

Follow us